A glance at what’s happening in the world of technology.
Gene therapy study offers hope to IRD sufferers
The visual function of mice suffering from inherited retinal disease (IRD) was restored in a US study hailed as a breakthrough.
Researchers from the University of California, Irvine (UCI), used new-generation CRISPR technology – known as base editing – to demonstrate a new therapeutic modality for a wide range of IRDs.
Co-author Krzysztof Palczewski, professor at the UCI’s Gavin Herbert Eye Institute, said: “We provide evidence of the clinical potential of base editors for the correction of mutations causing IRDs and for restoring visual function.
Sign in to continue
Not already a member of The College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
We believe that vaccine uptake will be maximised where staff are supported to make their own decisions, having been provided with clear, evidence-based information on the benefit and value of vaccinations.
Following the announcement by the Secretary for Health that the isolation period for people who test positive for COVID-19 will be cut to five full days in England, NHSE has confirmed this will apply in primary care settings.
